Selank
Synthetic peptide studied for anxiety and cognitive support, with evidence limited to small Russian clinical trials.
Selank
Synthetic peptide studied for anxiety and cognitive support, with evidence limited to small Russian clinical trials.
Skip unless you are participating in supervised research; evidence is too preliminary for general use.
Selank is a synthetic heptapeptide and tuftsin analog developed in Russia. It is primarily investigated as an anxiolytic and nootropic compound. Russian clinical studies suggest it may reduce anxiety without causing sedation or withdrawal. Limited small trials also examine cognitive performance under stress and immunomodulatory effects. It is not approved by the FDA or EMA and remains experimental outside Russia. Those considering it typically have treatment-resistant anxiety and are working with a clinician.
Proven Benefits
Protocol
Onset Time
Who Should Consider
How It Works
Selank is thought to modulate brain-derived neurotrophic factor (BDNF) expression and inhibit enkephalin-degrading enzymes, potentially enhancing GABAergic signaling. It may also influence interferon and cytokine production, though human mechanisms are not fully characterized.